{"filings":[{"id":94662,"accession_number":"0001681622-26-000051","cik":1681622,"company_name":"Varex Imaging Corp","ticker":"VREX","form_type":"8-K","filed_at":"2026-05-07T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Varex Q2 revenue $216M (+1% YoY), GAAP EPS -$0.19; guides FY26 rev $860-880M, non-GAAP EPS $0.80-1.00","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $216M (+1% YoY); Medical $156M, Industrial $60M.","GAAP net loss $0.19/diluted share; Non-GAAP net income $0.21/diluted share.","Non-GAAP gross margin 34% (down from 36% YoY); cash outflows ops $2M; cash $88M (down from $155M).","FY26 guidance: revenue $860-880M, non-GAAP EPS $0.80-1.00; Q3FY26 rev $210-225M, non-GAAP EPS $0.15-0.30.","CEO cites momentum in CT, cargo, photon counting detectors; tariff refunds not assumed in guidance."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.14,"consensus_revenue_estimate":null,"consensus_revenue_actual":425600000.0,"consensus_period":"2026-Q2","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":392370000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":107193,"accession_number":"0001681622-26-000035","cik":1681622,"company_name":"Varex Imaging Corp","ticker":"VREX","form_type":"8-K","filed_at":"2026-03-16T23:59:59+00:00","items":["1.01","1.02","2.03","8.01","9.01"],"status":"ready","headline":"Varex closes $490M credit facility, redeems $368M 7.875% notes due 2027","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["New facility includes $350M term loan, $100M revolver, $40M delayed draw; matures March 13, 2031.","Redeemed all $368M of 7.875% Senior Secured Notes due 2027; used $42M cash including $7M call premium.","Borrowings at SOFR + 2.50% margin (3.65% fixed via swap); expected to reduce annualized interest by >$7M.","Terminated existing $155M revolver; no outstanding borrowings at termination.","CFO Maheshwari says refinancing strengthens balance sheet and improves cost of capital."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":392370000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":107192,"accession_number":"0001681622-26-000031","cik":1681622,"company_name":"Varex Imaging Corp","ticker":"VREX","form_type":"8-K","filed_at":"2026-02-13T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Varex Imaging shareholders elect all seven director nominees at 2026 annual meeting","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["All seven director nominees elected with >34M votes for each; broker non-votes ~3.4M.","Advisory say-on-pay approved: 33,985,913 for, 1,004,141 against, 167,107 abstain.","Ratification of Deloitte & Touche as auditor for FY2026: 38,106,353 for, 301,360 against.","Meeting had ~92% of outstanding shares represented (38,575,226 shares) forming a quorum."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.15,"market_cap_usd":392370000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":107191,"accession_number":"0001681622-26-000015","cik":1681622,"company_name":"Varex Imaging Corp","ticker":"VREX","form_type":"8-K","filed_at":"2026-02-10T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Varex Q1 revenue $210M (+5% YoY), Non-GAAP EPS $0.19, guides Q2 rev $210-225M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["GAAP net income $0.05 per diluted share; Non-GAAP EPS $0.19 (up from $0.10 YoY).","Medical segment revenue $145M; Industrial segment $65M (+17% YoY on cargo systems strength).","Cash outflow from operations $16M; cash & equivalents $126M (down from $155M).","Q2 FY2026 guidance: revenue $210-225M, Non-GAAP EPS $0.15-0.25.","Results at high-end of guidance; demand for CT and cargo security remains strong."],"consensus_eps_estimate":null,"consensus_eps_actual":0.05,"consensus_revenue_estimate":null,"consensus_revenue_actual":209600000.0,"consensus_period":"2026-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":392370000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":123527,"accession_number":"0001681622-25-000106","cik":1681622,"company_name":"Varex Imaging Corp","ticker":"VREX","form_type":"8-K","filed_at":"2025-11-18T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Varex Q4 revenue $229M (+11% YoY); Non-GAAP EPS $0.37; guides Q1 $200-215M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 FY25 revenue $229M, up 11% YoY; Medical segment $152M (+5%), Industrial $77M (+25%).","GAAP diluted EPS $0.29; Non-GAAP diluted EPS $0.37, up from $0.19 in Q4 FY24.","FY25 revenue $845M (+4% YoY); Non-GAAP EPS $0.90 (+73%); Non-GAAP EBITDA $122M (+37%).","Cash & securities $155M at FY25 end, down from $213M due to convertible debt paydown in June 2025.","Q1 FY26 guidance: revenue $200-215M, Non-GAAP EPS $0.05-0.25."],"consensus_eps_estimate":null,"consensus_eps_actual":-1.7,"consensus_revenue_estimate":null,"consensus_revenue_actual":844600000.0,"consensus_period":"2025-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":392370000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":140205,"accession_number":"0001681622-25-000090","cik":1681622,"company_name":"Varex Imaging Corp","ticker":"VREX","form_type":"8-K","filed_at":"2025-09-11T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Varex SVP & CLO Kimberley Honeysett to transition; advisory role through Dec 2027","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Kimberley Honeysett steps down as CLO effective Oct 3, 2025, then remains as non-executive employee/advisor until Dec 12, 2027.","During FY2026 she receives current salary and bonus eligibility; thereafter $100,000/year plus health benefits.","Outstanding equity awards continue to vest through the Continued Service Period; no new equity grants.","Company may terminate with Cause; Transition Agreement includes mutual general releases and indemnification."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":392370000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":140204,"accession_number":"0001681622-25-000083","cik":1681622,"company_name":"Varex Imaging Corp","ticker":"VREX","form_type":"8-K","filed_at":"2025-08-07T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Varex Q3 revenue $203M beats guidance; GAAP loss $(2.15), non-GAAP profit $0.18","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue of $203M down 3% YoY but above high-end guidance; Industrial segment up 1% to $61M, Medical down 4% to $142M.","GAAP net loss of $(2.15) per diluted share; non-GAAP net earnings of $0.18 per diluted share, up from $0.14 YoY.","Cash flow from operations $8M; cash and securities $153M down from $226M prior quarter due to Convertible Notes paydown.","Q4 FY2025 guidance: revenue $210M-$230M, non-GAAP EPS $0.10-$0.30.","CEO expects fiscal 2025 sales growth of ~3%, citing strong cargo inspection and healthy demand in both segments."],"consensus_eps_estimate":null,"consensus_eps_actual":-2.0,"consensus_revenue_estimate":null,"consensus_revenue_actual":615700000.0,"consensus_period":"2025-Q3","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":392370000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":157851,"accession_number":"0001681622-25-000061","cik":1681622,"company_name":"Varex Imaging Corp","ticker":"VREX","form_type":"8-K","filed_at":"2025-05-08T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Varex Q2 revenue $213M (+3% YoY); China tariff pause cuts Q3 outlook to $180-200M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["GAAP EPS $0.17, Non-GAAP EPS $0.26 vs $0.16 prior year.","Medical segment revenue $154M (+3% YoY); Industrial $59M (+3% YoY).","Cash flow from operations $17M; cash equivalents $226M excluding $125M restricted.","Plans to repay outstanding Convertible Notes due June 2025 upon maturity.","Q3 guidance: revenue $180-200M with China ~$10M; Non-GAAP EPS -$0.05 to $0.10."],"consensus_eps_estimate":0.0357,"consensus_eps_actual":0.16,"consensus_revenue_estimate":null,"consensus_revenue_actual":412700000.0,"consensus_period":"2025-Q2","consensus_source":"xbrl+finnhub","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":392370000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":157850,"accession_number":"0001681622-25-000050","cik":1681622,"company_name":"Varex Imaging Corp","ticker":"VREX","form_type":"8-K","filed_at":"2025-04-04T23:59:59+00:00","items":["7.01"],"status":"ready","headline":"China MOFCOM launches anti-dumping probe on CT X-ray tubes; Varex could be impacted","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["China MOFCOM announced anti-dumping investigation into medical CT X-ray tubes from US and India.","Varex produces tubes in the US and ships to China; does not produce in India.","Company has not received formal notice; believes it complies with competition laws.","Varex states it will cooperate should it receive formal notice."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":392370000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":176233,"accession_number":"0001681622-25-000018","cik":1681622,"company_name":"Varex Imaging Corp","ticker":"VREX","form_type":"8-K","filed_at":"2025-02-14T23:59:59+00:00","items":["5.03","5.07","9.01"],"status":"ready","headline":"Varex stockholders approve officer exculpation amendment; re-elect all directors","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["All seven director nominees elected with 34.2M to 35.0M votes for; brokers non-voted 2.6M shares.","Advisory say-on-pay resolution passed: 34.2M for, 1.0M against, 2.6M broker non-votes.","Advisory frequency of say-on-pay set at one year: 33.1M for one year, 2.1M for three years.","Officer exculpation amendment to Certificate of Incorporation approved: 28.8M for, 6.5M against.","Ratification of Deloitte & Touche as independent auditor for FY2025: 37.7M for, 0.2M against."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"market_cap_usd":392370000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":176232,"accession_number":"0001681622-25-000013","cik":1681622,"company_name":"Varex Imaging Corp","ticker":"VREX","form_type":"8-K","filed_at":"2025-02-06T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Varex Q1 FY2025 revenue up 5% YoY to $200M; GAAP net loss $0.01/sh, Non-GAAP EPS $0.07","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Medical segment revenue $145M (+3% YoY); Industrial segment revenue $55M (+10% YoY).","Non-GAAP gross margin improved to 35% from 31% in prior-year quarter.","Cash flow from operations $10M; cash & securities $219M vs $213M at FY2024 year-end.","Q2 FY2025 guidance: revenue $200-215M, Non-GAAP EPS $0.05-0.20.","CEO cited solid demand and favorable sales mix driving higher-than-expected profitability."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.01,"consensus_revenue_estimate":null,"consensus_revenue_actual":199800000.0,"consensus_period":"2025-Q1","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":392370000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":176231,"accession_number":"0001681622-25-000003","cik":1681622,"company_name":"Varex Imaging Corp","ticker":"VREX","form_type":"8-K/A","filed_at":"2025-01-06T23:59:59+00:00","items":["1.02"],"status":"ready","headline":"Varex terminates $20M equipment credit facility after senior secured notes offering","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Equipment Credit Agreement with Zions terminated effective Dec 20, 2024, confirmed Jan 3, 2025.","Facility of up to $20M was no longer needed following December 20, 2024 senior secured notes offering.","No amounts were outstanding under the terminated agreement; no early termination penalty incurred.","Original 8-K filed Dec 23, 2024; this amendment supplements Item 1.02 with closure confirmation."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":392370000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":193121,"accession_number":"0001681622-24-000119","cik":1681622,"company_name":"Varex Imaging Corp","ticker":"VREX","form_type":"8-K","filed_at":"2024-12-23T23:59:59+00:00","items":["1.01","1.02","2.03","8.01","9.01"],"status":"ready","headline":"Varex closes $125M 7.875% senior secured notes due 2027 for convertible note repayment","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["$125M aggregate principal at 101.5% of par, 7.875% coupon, maturing 2027.","Net proceeds ~$124M to partially repay $200M convertible notes due June 2025.","Additional notes are part of same issue as existing $300M notes ($243M outstanding).","Company to terminate unused $20M equipment credit agreement post-closing.","CFO states offering preserves availability under revolving credit facility."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":392370000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":193120,"accession_number":"0001681622-24-000104","cik":1681622,"company_name":"Varex Imaging Corp","ticker":"VREX","form_type":"8-K","filed_at":"2024-12-17T23:59:59+00:00","items":["1.01","8.01","9.01"],"status":"ready","headline":"Varex prices $125M add'l 7.875% senior secured notes due 2027 to repay convertible notes","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["$125M aggregate principal of 7.875% senior secured notes due Oct 2027 priced at 101.5% of par.","Proceeds to fund partial repayment of outstanding Convertible Notes due June 2025.","Notes are additional issuance under existing indenture; $243M of original $300M notes still outstanding.","Closing expected Dec 20, 2024; Varex also intends to terminate $20M Equipment Credit Agreement.","Notes are senior secured, guaranteed by subsidiaries, with first and second liens on specified assets."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":392370000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":193119,"accession_number":"0001681622-24-000088","cik":1681622,"company_name":"Varex Imaging Corp","ticker":"VREX","form_type":"8-K","filed_at":"2024-11-19T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Varex Q4 FY24 revenue $206M; GAAP EPS loss $1.22, non-GAAP EPS $0.19","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["GAAP net loss of $1.22 per diluted share; non-GAAP EPS of $0.19, down from $0.45 YoY.","Total revenue $206M in Q4 FY24, down 10% YoY; full-year revenue $811M.","Medical segment revenue $144M (-12% YoY); Industrial $61M (-4% YoY).","Ended FY24 with $213M cash and marketable securities; operating cash flow $26M in Q4.","Q1 FY25 guidance: revenue $195-215M, non-GAAP EPS -$0.05 to $0.10."],"consensus_eps_estimate":null,"consensus_eps_actual":-1.17,"consensus_revenue_estimate":null,"consensus_revenue_actual":811000000.0,"consensus_period":"2024-FY","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":392370000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":209502,"accession_number":"0001681622-24-000083","cik":1681622,"company_name":"Varex Imaging Corp","ticker":"VREX","form_type":"8-K","filed_at":"2024-09-11T23:59:59+00:00","items":["8.01"],"status":"ready","headline":"Varex amends credit agreement to relax covenants on convertible note payments and leverage","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Amendment dated Sept 11, 2024 with Zions Bancorporation modifies Payment Conditions to allow restricted payments up to greater of 50% of CNI or $50M when leverage >2.50x.","Fixed Charge Coverage Ratio definition now excludes up to $200M in convertible note payments for covenant measurement.","For Q4 FY2024 and Q1/Q2 FY2025, cash deduction for leverage ratio calculation increased from $100M to $150M."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":392370000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":209501,"accession_number":"0001681622-24-000068","cik":1681622,"company_name":"Varex Imaging Corp","ticker":"VREX","form_type":"8-K","filed_at":"2024-08-01T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Varex Q3 FY2024 revenue down 10% YoY; Q4 guidance weak","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $209M (-10% YoY); GAAP EPS $0.03, Non-GAAP EPS $0.14 vs $0.37 YoY.","Medical segment revenue $149M (-15% YoY); Industrial segment $60M (+6% YoY).","Cash flow from operations $8M; cash and equivalents $192M (flat vs FY2023).","Q4 FY2024 guidance: revenue $190-210M, Non-GAAP EPS $0.00-$0.15, citing challenging market conditions."],"consensus_eps_estimate":null,"consensus_eps_actual":0.06,"consensus_revenue_estimate":null,"consensus_revenue_actual":605300000.0,"consensus_period":"2024-Q3","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":392370000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":227573,"accession_number":"0001681622-24-000058","cik":1681622,"company_name":"Varex Imaging Corp","ticker":"VREX","form_type":"8-K","filed_at":"2024-05-02T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Varex Q2 revenue $206M, down 10% YoY; lowers H2 outlook due to China softness","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $206M, down 10% YoY; GAAP EPS $0.03, Non-GAAP EPS $0.16 (down from $0.26).","Medical segment revenue $149M (-15% YoY); Industrial $57M (+6% YoY).","Non-GAAP gross margin 33% flat YoY; operating cash flow $3M.","Q3 guidance: revenue $200-220M, non-GAAP EPS $0.05-$0.25; management lowered H2 expectations.","CEO cited continued softness in China as primary headwind for medical segment."],"consensus_eps_estimate":null,"consensus_eps_actual":0.02,"consensus_revenue_estimate":null,"consensus_revenue_actual":396200000.0,"consensus_period":"2024-Q2","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":392370000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":246391,"accession_number":"0001681622-24-000052","cik":1681622,"company_name":"Varex Imaging Corp","ticker":"VREX","form_type":"8-K","filed_at":"2024-03-27T23:59:59+00:00","items":["1.01","1.02","2.03","8.01","9.01"],"status":"ready","headline":"Varex closes $155M senior secured revolving credit facility with Zions, replaces prior ABL","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["New $155M senior secured revolving credit facility matures September 26, 2027.","Interest rate: SOFR + 2.00%-2.75% margin; base rate option; unused fee 0.30%-0.40%.","Proceeds for working capital, general corporate purposes, potential debt repayment.","Collateral: first lien on inventory, AR, cash; second lien on assets securing 7.875% Senior Secured Notes.","Existing ABL credit facility terminated simultaneously with no outstanding balance."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":392370000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":246390,"accession_number":"0001681622-24-000014","cik":1681622,"company_name":"Varex Imaging Corp","ticker":"VREX","form_type":"8-K","filed_at":"2024-02-09T23:59:59+00:00","items":["5.07","9.01"],"status":"ready","headline":"Varex Imaging shareholders elect directors, approve amended equity plan at 2024 annual meeting","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["All seven director nominees elected with ~92% of shares represented; vote results filed.","Advisory vote on executive compensation approved with 33.3M for vs 1.6M against.","Amended 2020 Omnibus Stock Plan approved, adding 5.8M shares authorized for future awards.","Deloitte & Touche ratified as independent auditor for FY2024 with 37.2M for.","Amended plan as of February 9, 2024; restated terms included in Exhibit 10.1."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.15,"market_cap_usd":392370000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":246389,"accession_number":"0001681622-24-000008","cik":1681622,"company_name":"Varex Imaging Corp","ticker":"VREX","form_type":"8-K","filed_at":"2024-02-06T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Varex Q1 FY2024 revenue $190M (-8% YoY), GAAP loss $0.01/sh, non-GAAP EPS $0.06","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $190M, down 8% YoY; Medical segment $140M (-13%), Industrial $50M (+10%).","GAAP net loss $0.01/diluted share; Non-GAAP EPS $0.06 vs $0.21 in prior year.","Non-GAAP gross margin 31% (vs 32% YoY); operating margins declined.","Cash from operations $10M; cash & equivalents $195M, flat vs FY2023 year-end.","Q2 FY2024 guidance: revenue $195-215M, non-GAAP EPS $0.10-$0.30."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.01,"consensus_revenue_estimate":null,"consensus_revenue_actual":190000000.0,"consensus_period":"2024-Q1","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":392370000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":null}